176 related articles for article (PubMed ID: 30582180)
1. The utility of a point-of-care sural nerve conduction device for detection of diabetic polyneuropathy: A cross-sectional study.
Kural MA; Andersen ST; Andersen NT; Andersen H; Charles M; Finnerup NB; Jensen TS; Tankisi H
Muscle Nerve; 2019 Feb; 59(2):187-193. PubMed ID: 30582180
[TBL] [Abstract][Full Text] [Related]
2. Reliability and validity of a point-of-care sural nerve conduction device for identification of diabetic neuropathy.
Lee JA; Halpern EM; Lovblom LE; Yeung E; Bril V; Perkins BA
PLoS One; 2014; 9(1):e86515. PubMed ID: 24466129
[TBL] [Abstract][Full Text] [Related]
3. Validation of a novel point-of-care nerve conduction device for the detection of diabetic sensorimotor polyneuropathy.
Perkins BA; Grewal J; Ng E; Ngo M; Bril V
Diabetes Care; 2006 Sep; 29(9):2023-7. PubMed ID: 16936147
[TBL] [Abstract][Full Text] [Related]
4. Assessment of diabetic neuropathy using a point-of-care nerve conduction device shows significant associations with the LDIFLARE method and clinical neuropathy scoring.
Sharma S; Vas PR; Rayman G
J Diabetes Sci Technol; 2015 Jan; 9(1):123-31. PubMed ID: 25231114
[TBL] [Abstract][Full Text] [Related]
5. Medial plantar and dorsal sural nerve conduction studies increase the sensitivity in the detection of neuropathy in diabetic patients.
Uluc K; Isak B; Borucu D; Temucin CM; Cetinkaya Y; Koytak PK; Tanridag T; Us O
Clin Neurophysiol; 2008 Apr; 119(4):880-5. PubMed ID: 18291716
[TBL] [Abstract][Full Text] [Related]
6. Point-of-care nerve conduction device predicts the severity of diabetic polyneuropathy: A quantitative, but easy-to-use, prediction model.
Kamiya H; Shibata Y; Himeno T; Tani H; Nakayama T; Murotani K; Hirai N; Kawai M; Asada-Yamada Y; Asano-Hayami E; Nakai-Shimoda H; Yamada Y; Ishikawa T; Morishita Y; Kondo M; Tsunekawa S; Kato Y; Baba M; Nakamura J
J Diabetes Investig; 2021 Apr; 12(4):583-591. PubMed ID: 32799422
[TBL] [Abstract][Full Text] [Related]
7. Validity of a point-of-care nerve conduction device for polyneuropathy identification in older adults with diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes.
Scarr D; Lovblom LE; Cardinez N; Orszag A; Farooqi MA; Boulet G; Weisman A; Lovshin JA; Ngo M; Paul N; Keenan HA; Brent MH; Cherney DZ; Bril V; Perkins BA
PLoS One; 2018; 13(4):e0196647. PubMed ID: 29709021
[TBL] [Abstract][Full Text] [Related]
8. Validity and reliability of a point-of-care nerve conduction device in diabetes patients.
Shibata Y; Himeno T; Kamiya T; Tani H; Nakayama T; Kojima C; Sugiura-Roth Y; Naito E; Kondo M; Tsunekawa S; Kato Y; Nakamura J; Kamiya H
J Diabetes Investig; 2019 Sep; 10(5):1291-1298. PubMed ID: 30659760
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of dorsal sural nerve conduction studies in healthy and diabetic children.
Turgut N; Karasalihoglu S; Kücükugurluoglu Y; Balci K; Ekuklu G; Tütüncüler F
Clin Neurophysiol; 2004 Jun; 115(6):1452-6. PubMed ID: 15134714
[TBL] [Abstract][Full Text] [Related]
10. Whole plantar nerve conduction study: A new tool for early diagnosis of peripheral diabetic neuropathy.
Galiero R; Ricciardi D; Pafundi PC; Todisco V; Tedeschi G; Cirillo G; Sasso FC
Diabetes Res Clin Pract; 2021 Jun; 176():108856. PubMed ID: 33965449
[TBL] [Abstract][Full Text] [Related]
11. Difference in normal limit values of nerve conduction parameters between Westerners and Japanese people might need to be considered when diagnosing diabetic polyneuropathy using a Point-of-Care Sural Nerve Conduction Device (NC-stat®/DPNCheck™).
Hirayasu K; Sasaki H; Kishimoto S; Kurisu S; Noda K; Ogawa K; Tanaka H; Sakakibara Y; Matsuno S; Furuta H; Arita M; Naka K; Nanjo K
J Diabetes Investig; 2018 Sep; 9(5):1173-1181. PubMed ID: 29430866
[TBL] [Abstract][Full Text] [Related]
12. Simplified electrodiagnostic criteria of diabetic polyneuropathy in field study (KCIS No. 14).
Hsu WC; Chiu YH; Chen WH; Chiu HC; Liou HH; Chen TH
Neuroepidemiology; 2007; 28(1):50-5. PubMed ID: 17215587
[TBL] [Abstract][Full Text] [Related]
13. Point-of-care sural nerve conduction could predict the presence of cardiovascular autonomic neuropathy in type 1 diabetes mellitus.
Nattero-Chávez L; Luque-Ramírez M; Quiñones-Silva J; Montánez L; Fernández-Durán E; Dorado-Avendaño B; Escobar-Morreale HF
J Diabetes Investig; 2022 Aug; 13(8):1347-1356. PubMed ID: 35389567
[TBL] [Abstract][Full Text] [Related]
14. Comparison of diabetic neuropathy symptom score and medial plantar sensory nerve conduction studies in diabetic patients showing normal routine nerve conduction studies.
An JY; Park MS; Kim JS; Shon YM; Lee SJ; Kim YI; Lee KS; Kim BJ
Intern Med; 2008; 47(15):1395-8. PubMed ID: 18670144
[TBL] [Abstract][Full Text] [Related]
15. Bilateral nerve conduction studies in the evaluation of distal symmetric polyneuropathy.
Dupuis JE; Li J; Callaghan BC; Reynolds EL; London ZN
Muscle Nerve; 2019 Sep; 60(3):305-307. PubMed ID: 31228276
[TBL] [Abstract][Full Text] [Related]
16. Medial plantar-to-radial amplitude ratio: does it have electrodiagnostic utility in distal sensory polyneuropathy?
Kahraman Koytak P; Alibas H; Omercikoglu Ozden H; Tanridag T; Uluc K
Int J Neurosci; 2017 Apr; 127(4):356-360. PubMed ID: 27043973
[TBL] [Abstract][Full Text] [Related]
17. The role of blink reflex R1 latency as an electrophysiological marker in diabetic distal symmetrical polyneuropathy.
Lai YR; Huang CC; Chiu WC; Liu RT; Tsai NW; Wang HC; Lin WC; Cheng BC; Su YJ; Su CM; Hsiao SY; Wang PW; Chen JF; Ko JY; Lu CH
Clin Neurophysiol; 2020 Jan; 131(1):34-39. PubMed ID: 31751837
[TBL] [Abstract][Full Text] [Related]
18. Sural-to-radial amplitude ratio in the diagnosis of diabetic sensorimotor polyneuropathy.
Barnett C; Perkins BA; Ngo M; Todorov S; Leung R; Bril V
Muscle Nerve; 2012 Jan; 45(1):126-7. PubMed ID: 22190318
[TBL] [Abstract][Full Text] [Related]
19. A comparison of sural nerve conduction studies in patients with impaired oral glucose tolerance test.
Koçer A; Domaç FM; Boylu E; Us O; Tanridağ T
Acta Neurol Scand; 2007 Dec; 116(6):399-405. PubMed ID: 17986099
[TBL] [Abstract][Full Text] [Related]
20. One-stop microvascular screening service: an effective model for the early detection of diabetic peripheral neuropathy and the high-risk foot.
Binns-Hall O; Selvarajah D; Sanger D; Walker J; Scott A; Tesfaye S
Diabet Med; 2018 Jul; 35(7):887-894. PubMed ID: 29608799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
